Intellectual Property India Publishes Patent Application for Klrb1 Binding Agents And Methods Of Use Thereof

MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617074647 A) filed by The Brigham And Women'S Hospital, Inc. on June 16, 2026, for Klrb1 Binding Agents And Methods Of Use Thereof.

Inventor includes Greenberg, Steven A..

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: KLRB1 binding agents (in particular anti-KLRB1-antibodies and antigen binding portion thereof) with increased humanness and compositions thereof, as well as therapeutic methods of using the agents, e.g., for depleting cells or inhibiting cells or activating cells, (in particular, Th17, Th17.1, ex-Th17, Tc17, MAIT, iNKT, peTh2, ILC2, ILC3, NK cells, and/or neoplastic T or NK cells in vivo), for the treatment of autoimmune disease, allergic diseases, transplant rejection, hematologic malignancies, and cancer.

Disclaimer: Curated by HT Syndication.